Ramkumar Govindaraj retweetledi
Ramkumar Govindaraj
70 posts
Ramkumar Govindaraj
@ramkumargo
Radiation Oncologist, Royal Adelaide Hospital @SAHealth. Clinical Senior Lecturer, The University of Adelaide.
Katılım Mart 2010
73 Takip Edilen57 Takipçiler
Ramkumar Govindaraj retweetledi
New in JMIR: Assessing ##Patient-Reported Outcomes in Routine #Cancer Clinical Care Using Electronic Administration and #Telehealth Technologies: Realist Synthesis of Potential Mechanisms for Improving Health Outcomes dlvr.it/SzR1CQ
English
Ramkumar Govindaraj retweetledi
Ramkumar Govindaraj retweetledi
Paper available!
Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions redjournal.org/article/S0360-…
#ASTRO22 #ASTRO2022
Marcelino Hermida López@marslain
Dose-Escalated Two-Fraction Spine Stereotactic Body Radiotherapy: 28 Gy vs. 24 Gy in 2 Daily Fractions redjournal.org/article/S0360-… 28 Gy in 2 daily fractions was associated with improved local control without increasing the risk of vertebral compression fracture. #ASTRO2022
English
Ramkumar Govindaraj retweetledi
Ramkumar Govindaraj retweetledi
New #OpenAccess review | Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @imrtlee @MSK_RadOnc @MSKCancerCenter
English
Ramkumar Govindaraj retweetledi
Drs Jennie Roberts, Angela Allen and Tuan Ha are our convenors for the 2023 ASM. Our co-convenors introduced the theme for next year at the #RANZCR2022 Gala Dinner, which is BEYOND. We look forward to welcoming you to Brisbane from 19-22 October 2023.
#RANZCR2023
English
Ramkumar Govindaraj retweetledi
5-yr Outcomes Ph III KN042 trial, Pembro v Chemo in 1L PDL1≥1% NSCLC @JCO_ASCO:
- HR OS in PDL1>50% 0.66, 5yr OS 21.9%
- HR OS in PDL1 1-49% 0.88, 95%CI crosses 1, 5yr OS 11.9%
- 33pts re-challenged w pembro, 15.2% ORR
@OncoAlert #LCSM ascopubs.org/doi/full/10.12…
CY
Ramkumar Govindaraj retweetledi
Today is Day 1 of Lung Cancer Awareness Month 2022 (#LCAM22). Fact: Did you know that #LungCancer causes more deaths globally than colon, breast, & prostate cancers combined? #LCSM
English
Ramkumar Govindaraj retweetledi
The conveners singing A Whole New World to kick off the Gala dinner ‘To Infinity and Beyond’ 💫 ⭐️ #RANZCR2022
Adelaide, South Australia 🇦🇺 English
Ramkumar Govindaraj retweetledi
So should be considering either 60/15 or SABR as a new standard of care for early stage centrally located NSCLC?
Any thoughts @finn_corinne @cpeedell @DavidDbal @_ShankarSiva @shalinivinod13 @fifimcdrmh @petra_jankowska @sjharrow @DrewMoghanaki #radonc #lcsm
Shankar Siva@_ShankarSiva
Late breaking #ASTRO22 - LUSTRE phase III N=233, randomised SABR vs conventional #radiotherapy in #lungcancer median F/U 3.1 yrs. BOTH central and peripheral tumours. Closed earlier than expected, no statistical diff between arms. So close!! 🫣 @OncoAlert #radonc #lcsm
English
Ramkumar Govindaraj retweetledi
SABR has an increasing role in the treatment of #NSCLC patients with oligometastatic disease
sciencedirect.com/science/articl…
@drdavidpalma @IyengarPuneeth 5/8
English
Ramkumar Govindaraj retweetledi
November is #lungcancerawarenessmonth. Did you know that #radiotherapy is an important modality in the Rx of #lungcancer but is often underutilized? @Eric73363938 @gerryhanna @ClinOncology onlinelibrary.wiley.com/doi/10.1111/re… 1/8
English
Ramkumar Govindaraj retweetledi
The abstract book for #RANZCR2022 is now online!
ow.ly/tL6h50LjNtQ
English
Ramkumar Govindaraj retweetledi
🚨New in @CAonline: Review of deintensification for HPV‐positive OPC #headandNeckCancer #hncsm. The future may lie in incorporating intra-tx response assessments to harness the powers of personalized medicine & integrate real-time surveillance. #hncsm
👉acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…
English
Ramkumar Govindaraj retweetledi
The effect of cochlear dose on hearing preservation after low dose stereotactic radiosurgery for vestibular schwannomas: a systematic review advancesradonc.org/article/S2452-…
A practical approach will be to aim for a mean cochlear dose ˂ 4-6 Gy without compromising tumour dose.
English
Ramkumar Govindaraj retweetledi
To Infinity and Beyond. Thank you to @GEHealthcare for sponsoring last night's Gala Dinner at the Adelaide Convention Centre. Thank you to Ms Julia Keraand, MR Leader for Australia/New Zealand, for joining us on stage last night. Thank you to everyone who attended.
#RANZCR2022
English
Ramkumar Govindaraj retweetledi
This voluntary, RANZCR approved ANZPROG survey uses 5 case studies to assess the current utilisation of advanced palliative RT techniques & technologies in Australia & New Zealand. Responses will be de-identified & reported in aggregate only.
ow.ly/7FRL50Lh54X
English
Ramkumar Govindaraj retweetledi
In good news, our radiologists at UCLA already know this. Do yours? #radonc radiologybusiness.com/topics/healthc…
English
Ramkumar Govindaraj retweetledi
To Infinity and Beyond. Thank you to everyone who attended the RANZCR 2022 ASM Gala Dinner last night. It was a wonderful evening.
#RANZCR2022
English